News

Monthly Prescribing Reference12y
Humate-p
Antihemophilic Factor VIII/Von Willebrand Factor Complex (human) 250 IU FVIII + 600 IU VWF, 500 IU FVIII + 1200 IU VWF, 1000 IU FVIII + 2400 IU VWF; per vial; lyophilized pwd for IV infusion after ...
pharmaphorum4y
Takeda’s bleeding disorder drug Veyvondi backed for NHS use
Since many situations requiring VWF replacement do not also require Factor VIII, the drug “offers clinicians the flexibility to dose vonicog alfa with or without [recombinant Factor VIII] based ...
The American Journal of Managed Care4y
Comparing Factor Use and Bleed Rates in US Hemophilia A Patients Receiving Prophylaxis With 3 Different Long-Acting Recombinant Factor VIII Products
For the switch analysis, data were collected about the FVIII products patients used before switching to rVIII-SingleChain. The same methods used for the cohort analysis (described above ...